Side-by-Side Comparison
LLY vs NVO
GLP-1 leaders. Compare price, valuation, growth, profitability, and balance-sheet quality — all in one view.
LLY wins 4·NVO wins 9·Updated daily
LLY
Eli Lilly and Company
Healthcare
$1,015.75
+261.45%
NVO
Novo Nordisk A/S
Healthcare
$47.08
+17.02%
Metric
LLY
NVO
Price
Last traded price
$1,015.75
$47.08
Day Change
Latest session move
+261.45%
+17.02%
Market Cap
Total equity value
$905.79B
$208.7B
P/E (TTM)
Trailing earnings multiple
36.1
10.9
Forward P/E
Forward earnings multiple
22.9
13.8
P/S
Price-to-sales ratio
12.54
0.64
EV/EBITDA
Enterprise value to EBITDA
25.4
1.9
Revenue (TTM)
Trailing twelve-month revenue
$72.25B
$327.8B
Revenue Growth
Year-over-year revenue growth
5550.0%
2400.0%
Profit Margin
Net income as % of revenue
3498.6%
3720.5%
Operating Margin
Operating income as % of revenue
4938.6%
6157.4%
Return on Equity
Net income as % of equity
10745.9%
7140.2%
Debt / Equity
Total debt vs equity
139.02
72.09
Free Cash Flow
Trailing FCF
$9.16B
$-12.04B
Dividend Yield
Annualized yield
7000.00%
100.00%
Beta
Volatility vs market
0.48
0.35
52W High
12-month high
$1,133.95
$81.44
52W Low
12-month low
$623.78
$35.12
Highlighted values indicate the better reading for that metric, where direction is unambiguous. Lower is generally better for valuation multiples and leverage; higher is better for growth, margin, and cash-flow metrics. Educational data only, not investment advice.
Go deeper than a side-by-side.
Add LLY and NVO to your Meridian watchlist for live alerts, AI-driven setups, and full earnings coverage.